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Abstract
Bisphenol A (BPA) is used in numerous products, such as plastic bottles and food containers, from which it frequently
leaches out and is consumed by humans. There is a growing public concern that BPA exposure may pose a significant threat
to human health. Moreover, due to the widespread and constant nature of BPA exposure, not only adults but fetuses and
neonates are also exposed to BPA. There is mounting evidence that developmental exposures to chemicals from our
environment, including BPA, contribute to diseases late in life; yet, studies of how early life exposures specifically alter the
immune system are limited. Herein we report an examination of how maternal exposure to a low, environmentally relevant
dose of BPA affects the immune response to infection with influenza A virus. We exposed female mice during pregnancy
and through lactation to the oral reference dose for BPA listed by the US Environmental Protection Agency, and
comprehensively examined immune parameters directly linked to disease outcomes in adult offspring following infection
with influenza A virus. We found that developmental exposure to BPA did not compromise disease-specific adaptive
immunity against virus infection, or reduce the host’s ability to clear the virus from the infected lung. However, maternal
exposure to BPA transiently reduced the extent of infection-associated pulmonary inflammation and anti-viral gene
expression in lung tissue. From these observations, we conclude that maternal exposure to BPA slightly modulates innate
immunity in adult offspring, but does not impair the anti-viral adaptive immune response, which is critical for virus
clearance and survival following influenza virus infection.
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Introduction
Bisphenol A (BPA) is a component of polycarbonate plastics and
epoxy resins used in a variety of products including food and
beverage containers, electronic appliances, dental sealants, paper
currency, and receipts [1]. The widespread use of BPA results in
an extremely high prevalence of human exposure; for example,
about 93% of the United States population has detectable levels of
BPA in their urine or blood [2]. This has generated substantial
concern because numerous studies show that BPA acts as
‘‘endocrine disruptor,’’ binding to estrogen and thyroid receptors,
and possibly acting via other pathways, to cause variety of
deleterious health effects [3–6]. Work in animal models has fueled
concern about the potential harmful effects of BPA to human
health, such as abnormalities in reproductive and brain develop-
ment, gene expression patterns, as well as body weight and altered
social behaviors [7–9]. Moreover, a commonality among many of
these reports is that BPA exposure during pregnancy or shortly
after birth is linked to exacerbated disease later in life. Exposure to
endocrine disruptors in utero or shortly after birth may be even
more detrimental than exposure during adulthood because key
developmental processes may be permanently altered, leading to
negative consequences that last for the lifetime of the offspring.
With regard to BPA, this is clearly a possibility as fetuses and
neonates are exposed to BPA from maternal sources, both in utero
and via breast milk, as well as from BPA that leaches from food
containers and other products [1,10,11]. Indeed, there is
compelling evidence in animal models that maternal exposure to
even minute amounts of BPA affects numerous physiological
systems in the offspring.
Due to its intricate relationship with the endocrine system, the
immune system is a particularly vulnerable target for potentially
deleterious effects of maternal exposure to endocrine disrupting
agents. Yet, few studies have explicitly examined the relationship
between maternal exposure to BPA and altered immune function
in the offspring. A handful of epidemiological studies have
examined this question, and the findings are mixed, with some
finding a possible correlation between urinary BPA levels and
metrics of immune function or disease, but other studies not
finding a relationship [12–15]. Immunomodulatory effects of
prenatal BPA exposure, such as a type-2 skewed cytokine response
in the offspring have also been reported in several animal studies
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these findings to human health because some effects of BPA were
only observed when high doses and/or routes of exposure that are
considered less relevant to human exposure were used [20,21].
Therefore, the consequence of low, environmentally relevant
developmental exposures to BPA on the function of the immune
system remains uncertain.
Early life exposure to BPA could alter the development and
maturation of immune cells, such that key host defense and
immunoregulatory mechanisms are impaired later in life. Other
possible consequences of early life exposure to BPA include
more subtle changes, such as altered functional capacity of
leukocytes upon antigen challenge, changes in leukocyte
trafficking, and/or cell-to-cell communication pathways that
are critical for a properly controlled immune response. In any
of these situations, BPA could broadly affect all leukocytes, or
selectively modulate the function of a particular lineage. Given
that the immune system encompasses an integrated and
complex network aimed at finding and eliminating invading
pathogens and cancer cells, even subtle impairment could
decrease resistance to infection, reduce the efficacy of immuno-
logical memory, or impair tumor surveillance mechanisms.
Consequently, if developmental exposure to BPA disturbs any of
these processes, it would create a situation in which immune
responses are imbalanced and responses to challenge are skewed
in a way that is less favorable to the host. The potential impact
of these types of changes on human health is tremendous.
In the present study, we determined whether maternal
exposure to BPA influences the long-term function of the
offspring’s immune system using a mouse model of lower
respiratory tract infection with human influenza A virus. This
model system is useful to assess the developmental immunotox-
icity of BPA because we can examine host resistance and
quantitatively measure multiple disease-specific endpoints
[22,23]. When influenza viruses enter the respiratory tract,
they prompt a series of events that usually lead to successful
viral clearance 8–10 days later. The response to infection
initially involves innate mediators such as macrophages,
neutrophils, cytokines and chemokines, which collectively strive
to control viral infection until the adaptive arm of the immune
response is fully engaged [24]. The adaptive immune response
to influenza virus includes CD4
+ and CD8
+ T cells, as well as
antibody producing B cells [24]. Of these, the generation of
virus-specific cytotoxic CD8
+ T cells in lymphoid tissues, which
emigrate to the lung and kill infected cells, are the principal
means for host resistance during a primary viral infection
[25,26]. In fact, CD8
+ T cells are especially critical for newly
emerging strains of influenza virus, where cross-protective
antibody mediated responses to viral surface proteins are often
absent or less robust. CD4
+ T cells do not generally kill
influenza virus infected host cells directly. Instead, these cells
instruct antibody isotype switching in B cells and regulate
immunological memory [27,28]. Virus-specific antibodies pro-
vide critical defenses from repeated infection with homotypic
virus strains [29]. Thus, insufficient adaptive immunity can
result in alterations in the response to primary and repeated
infection. We report herein an investigation of the consequences
of maternal exposure to the current oral reference dose of BPA
on these aspects of the host response to infection. We chose an
oral route of exposure to BPA because this represents the major
manner through which human exposure occurs [1], and we
administered a daily dose that yields systemic BPA levels in the
pregnant mice that are similar to levels reported in the general
population [2,12,30].
Materials and Methods
Animals
The specifications for the animal housing environment were
based on the guidelines outlined by an NIEHS expert panel for
BPA toxicity studies [31]. Adult C57BL/6 mice were purchased
from The Jackson Laboratory (Bar Harbor, ME) and housed in
pre-washed (BPA-free) polysulfone cages under pathogen free
conditions. Mice received phytoestrogen-free irradiated rodent
chow (AIN-76A, Test Diet, Richmond, IN) and water that was
purified by reverse osmosis and provided in glass bottles. The
Environmental Protection Agency reference dose for oral
exposure to BPA, which is 50 mg/kg of body weight/day [32],
was used in this investigation. Adult mice were paired for
breeding, and females were checked daily for vaginal plugs as
an indication of pregnancy. The day when a plug was found
was defined as the day 0 of gestation. Singly housed, plugged
females began receiving 50 mg BPA/kg body weight/day, or
vehicle alone (peanut oil) orally starting on gestational day (GD)
6 and continuing daily through postnatal day 21. Each pregnant
or lactating female mouse received BPA dissolved in 20 mlo f
peanut oil absorbed to a single additive-free puffed wheat
cereal, or administered by oral gavage in a volume of 200 ml.
Each mouse consumes the BPA-spiked food treats in approx-
imately 1 minute under observation, ensuring that an accurate
dose is administered to each mouse, on each day, in a stress
free manner. On postnatal day 21, all pups were weaned and
housed in same sex groups until ready for experimental
procedures (conducted when they reached 6–8 weeks of age).
All procedures involving laboratory animals were performed in
accordance with the protocols approved by the Institutional
Animal Care and Use Committee.
Measurement of BPA
Cardiac blood was collected from a subset of pregnant female
mice 4 hours following oral exposure to BPA or peanut oil vehicle.
The levels of BPA in blood plasma samples were measured using a
high performance liquid chromatography coupled with electro-
spray triple-quadrupole mass spectrometer [33]. The measure-
ment was done in the Laboratory of Organic Analytical
Chemistry, New York State Department of Health at Wadsworth
Center, Albany, NY.
Influenza Virus Infection
Sex matched adult (6–8 weeks old) offspring were intranasally
(i.n.) infected with influenza A virus in a final volume of 25 mlo f
endotoxin-tested PBS under general anesthesia (Avertin, 2,2,2-
tribromoethanol; Aldrich, Milwaukee, WI). Both male and female
offspring were used, but analyzed separately. For the primary
infections in this study, either 120 hemagglutinating units (HAU)
of influenza A/HKx31 (H3N2) (hereafter denoted as HKx31) or
50 foci forming units (FFU) of influenza A/CA/04/09 (H1N1)
virus was used. For secondary infections, 0.005 HAU of influenza/
A/PR/8/34 (H1N1) virus (hereafter denoted as PR8) was used.
Infected mice were monitored daily for body weight changes and
mortality.
Lung Histology
Groups of age- and sex-matched mice were sacrificed by
anesthetic overdose at the indicated points in time relative to
infection. The trachea was surgically exposed, and lungs were
fixed with 10% neutral buffered formalin (NBF) in-situ at constant
pressure under gravity. Fixed lungs were excised and embedded in
paraffin. 5 mm thick tissue sections were mounted on glass slides
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were based on inflammatory cell accumulation and tissue damages
observed under light microscope, as described previously [34].
Briefly, numerical scores were assigned to tissue sections as follows:
normal tissue without any cell accumulation = 0, nominal cell
infiltrates restricted to perivascular area = 1, sporadic cell
infiltration into the tissue parenchyma with consistent presence
of wide perivascular and peribronchiolar cuffing = 2, extensive
cell infiltration into the parenchyma = 3.
Virus Titer Assay
The pulmonary viral burden was measured by determining the
number of FFU present in lung homogenates [35]. Briefly, lungs
were harvested from infected mice and mechanically homoge-
nized. Serially diluted lung homogenates were incubated overnight
on confluent Madin-Darby canine kidney (MDCK) cells in 96 well
plates. The next day, plates were washed and foci of infection were
detected using biotin-conjugated influenza A virus nucleoprotein
specific antibodies (Millipore, Billerica, MA), followed by strepta-
vidin-conjugated alkaline phosphatase and BCIP-NBT as the color
developing substrate (Sigma-Aldrich, St. Louis, MO). Foci counts
were adjusted to the dilution of lung homogenate to determine the
total infectious virus particles in the entire lung; this is denoted in
the figures as FFU/lung.
Analysis of Gene Expression by Quantitative Real Time
(qRT)-PCR
Lungs from infected mice were mechanically homogenized on
ice and solubilized in Tri reagent (Molecular Research Center,
Cincinnati, OH). RNA was extracted using 1-bromo-3-chloropro-
pane (Molecular Research Center) as a phase separation agent,
and RNA sequestered in the aqueous layer was purified using
RNeasy kits (QIAGEN, Valencia, CA). cDNA libraries were
synthesized from 2 mg of total RNA using iScript reagents (BIO-
RAD, Hercules, CA). Levels of expression for different genes were
assessed by qRT-PCR, using approximately 50 ng of template
cDNA, gene specific primers, and BIORAD iQ-SYBR Green
Supermix, using a BIO-RAD iQ5. Expression of each gene in a
particular sample was normalized to the level of gene expression
for a ribosomal protein L-13 (housekeeping gene) in that sample as
previously described [36]. Transcript sequences were obtained
from NCBI database and primer properties were evaluated using
Primer3 software [37]. The primer sequences for all genes used are
listed in Table 1.
Characterization of Immune Cells by Flow Cytometry
Lungs, lung-draining mediastinal lymph nodes (MLN), and
spleens were removed from infected mice. Lung tissues were
digested with collagenase and DNase as described previously [38].
Cells from digested lungs were passed through 70 mm filter to
remove clumps and debris. Single cell suspensions of MLNs and
spleens were prepared by teasing the tissues apart between two
frosted glass slides. Erythrocytes were lysed in all samples using
hypotonic ammonium chloride buffer. Cells were washed,
counted, incubated with a mixture of rat IgG and anti-mouse
CD16/32 antibodies to prevent non-specific binding, and then
stained with fluorescent dye-conjugated antibodies against cell
surface markers CD3, CD4, CD8, CD25, CD44 and CD62L, and
the intracellular protein FoxP3 (eBioscience, San Diego, CA).
Virus-specific CD8
+ T cells were identified using MHC class-I
tetramers presenting nucleoprotein (NP366–374) and acid-polymer-
ase (PA224–233) peptide fragments of influenza A virus. Stained cells
were analyzed using an LSR-II flow cytometer (BD Bioscience,
Franklin Lakes, NJ) and results were analyzed using FlowJo
software (ver. 8.8.7, Tree Star, Ashland, OR).
Detection of Virus Specific Antibodies
Influenza A virus specific antibodies in blood plasma collected
from infected mice were measured using enzyme-linked immuno-
sorbent assay (ELISA) as described before [22]. Briefly, serially
diluted plasma samples were incubated in plates coated with
inactivated HKx31 virus (Charles River/Spafas, North River,
CT). Captured virus specific antibodies were detected using HRP
conjugated isotype specific anti-mouse antibodies (Southern
Biotech, Birmingham, AL) and H2O2-fortified ABTS substrate.
The absorbance of the substrate was measured at 405 nm using a
spectrophotometer.
Statistical Analyses
Since the dams, not the offspring, were given BPA, the
experimental ‘n’ refers to the number of treated dams, not the
number of offspring. All sex-matched adult offspring in each
treatment group and at each point in time after infection were
from a different treated dam. Statistical analyses were performed
using Prism 4.0 (GraphPad software, La Jolla, CA). For all data
sets depicted in each figure, statistical significance of the
differences in mean values between the endpoints measured in
vehicle versus BPA exposed groups were calculated using the
following tests with 95% confidence interval: Mantel-Haenszel log-
rank test for survival curves, two-way ANOVA with Bonferroni
Table 1. Primer sequences for gene expression analysis.
Gene Name Forward Primer Reverse Primer
TNF-a CAGGTTCTCTTCAAGGGACAAG GCAGAGAGGAGGTTGACTTTC
IL-6 CCTTCTTGGGACTGATGCTGGT GACAGGTCTGTTGGGAGTGGTATC
IFN-b AACTATAAGCAGCTCCAGCTCCA CTGCATCTTCTCCGTCATCTCCA
IFN-c AGCAACAACATAAGCGTCATT CCTCAAACTTGGCAATACTCA
RANTES GTGCTCCAATCTTGCAGTCGT AGGGAAGCGTATACAGGGTCA
IP-10 TACTGTAAGCTATGTGGAGGTGCG AACTTAGAACTGACGAGCCTGAGC
MCP-1 TAGGCTGGAGAGCTACAAGAGGAT CTCTCTCTTGAGCTTGGTGA
iNOS TGGCTACCACATTGAAGAAGCTG TCTGGCTCTTGAGCTGGAAGAAA
L-13 CTACAGTGAGATACCACACCAAG TGGACTTGTTTCGCCTCCTC
doi:10.1371/journal.pone.0038448.t001
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tailed unpaired Student’s t-test for all other immunological
parameters. An asterisk (*) is used to denote mean values for
which the p-value was less than 0.05. The absence of this marking
indicates that no statistically significant difference between mean
values was observed for that particular data set. Error bars on all
graphs represent standard error of the mean (SEM).
Results
Maternal Exposure to BPA did Not Change the Body
Weight of Either Pregnant Dams or the Offspring
Circulating BPA in pregnant mice was measured to validate
exposure from our method of oral delivery of BPA. Measurements
of BPA in blood (Fig. 1A) indicate that treated dams had
circulating BPA levels within the range reported in the general
human population [2,12,30]. Moreover, BPA levels in dams given
the peanut oil vehicle were significantly lower. Given that BPA is a
known endocrine disruptor and has been suggested to be an
obesogen [6,39,40], we monitored the body weight change of the
dams for the duration of pregnancy, starting from the first day of
BPA treatment (day 6 after detection of a vaginal plug) until
delivery. We also monitored sex ratios and body weight of the
offspring from birth to adulthood. We did not observe any
differences in the body weight of the dams, or their offspring when
comparing the vehicle and BPA treated groups (Fig. 1B & 1C).
Likewise, there were no differences in neonatal survival, litter size,
or the ratio of male-to-female offspring (data not shown).
Developmental Exposure to BPA did Not Alter the
Primary Outcomes of Influenza A Virus Infection
To examine the immunological competence of developmentally
exposed adult offspring, we infected them with influenza virus
(strain A/HKx31; H3N2) and examined a set of primary and
secondary disease outcomes in female and male adult offspring.
Primary outcomes included survival, changes in body weight as a
measure of morbidity, and the amount of virus in the lung.
Secondary outcomes included pulmonary inflammation, expres-
sion of key anti-viral genes, as well as virus-specific CD8
+ T cell
and antibody responses after primary and secondary infection.
Following primary infection, we did not observe any differences in
mortality, body weight change, or virus clearance from the lung,
when we compared mice that were developmentally exposed to
BPA to age- and sex-matched offspring of control-treated dams
(Fig. 2). Given that influenza A virus strain HKx31 is generally
considered to cause a relatively mild infection, we infected a
separate group of developmentally exposed mice with a more
lethal strain: influenza A virus CA/04/09 (H1N1). While this
caused $ 50% mortality, we observed no difference in morbidity
or mortality in the BPA- versus control-exposed groups (data not
shown).
Maternal BPA Exposure Altered Infection-associated
Changes in Lung Inflammation and Gene Expression
The equivalent capacity for virus clearance suggested that
developmental exposure might not overtly compromise aspects of
immune function crucial for surviving infection. This idea is
relevant because the global burden associated with influenza virus
stems less from mortality and more from the impact of infection-
related illness, resulting co-morbidities, and lost productivity. Two
aspects of the host immune response that often influence the
degree of illness are pulmonary inflammation and mediators of
anti-viral immunity [41,42]. Thus, to further evaluate whether
developmental exposure to BPA could have subtle effects on the
immune system, we examined pulmonary inflammation and
cytokine/chemokine gene expression levels in infected lung tissues.
We compared lung inflammation in mice developmentally
exposed to vehicle or BPA at three critical times following
influenza A virus infection: 1) during the peak of virus replication
in the lung (day 3 post-infection [p.i.]), 2) during early virus
clearance phase (day 7 p.i.), and 3) during the peak of CD8
+ T cell
mediated response, which ultimately clears virus from the lung and
generally dictates the overall outcome of the disease (day 10 p.i.).
As shown in Fig. 3, mice that were developmentally exposed to
BPA or vehicle control exhibited a similar degree of bronchopul-
monary inflammation the early stages of infection. However, there
was significantly less severe pulmonary inflammation 7 days after
infection. By day 10 p.i., the extent of inflammation returns to an
equivalent level in both groups of mice.
The reduction in lung inflammation 7 days after infection
suggests that there could be an attenuation of host antiviral
immune responses in the lungs of mice that were maternally
exposed to BPA. To further explore this possibility, the expression
level of several key immunoregulatory genes was assessed 3, 7 and
10 days following infection. We observed a general pattern of
reduced expression of genes for the cytokine TNF-a and the
chemokines RANTES (CCL5), IP-10 (CXCL10), and MCP-1
(CCL2) in lungs of infected mice that had been exposed to BPA
during development (Fig. 4), however, statistical significance of this
reduction was only found for some of these genes. We also
observed reduced expression levels of genes for interferon (IFN)-c
and inducible nitric oxide synthase (iNOS) in the lungs of BPA
exposed mice (Fig. 4). This is intriguing because expression of
iNOS and IFN-c by innate immune cells, such as macrophages
and neutrophils, influences lung pathology following influenza A
virus infection [43–46]. On the other hand, this was not a global
reduction in gene expression. Other genes, such as toll like
receptor (TLR)-3, IFN-b and interleukin (IL)-6, were altered by
influenza virus infection, but their level of expression was not
modulated by developmental BPA exposure (Fig. 4).
Developmental Exposure to BPA did Not Alter the
Adaptive Immune Response following Influenza Virus
Infection
Despite reduced expression of several genes for key immuno-
regulatory molecules and a transient reduction in lung inflamma-
tion in the BPA-exposed group, influenza virus was almost
completely cleared from the lungs by day 10 p.i. (Fig. 2). The
critically important immune effectors responsible for the clearance
of virus from the lung are virus-specific cytotoxic CD8
+ T
lymphocytes (CTL) [25,26]. The CD8
+ CTL response peaks about
9–10 days after HKx31 infection [24,25]. To determine whether
developmental exposure to BPA alters the CD8
+ T cell response to
influenza A virus infection, we isolated immune cells from lungs
and the lung-draining MLN 9 days after infection. We did not
detect any difference in the total number of CD8 T cells
(CD3
+CD8
+), cytotoxic effector T cells (CTLe,
CD3
+CD8
+CD44
hiCD62L
low) or virus antigen (NP or PA) specific
CD8 T cells when we compared lung and MLN cells isolated from
vehicle versus BPA exposed mice (Fig. 5A). Although the number
increases due to infection, developmental exposure to BPA did not
alter the number of CD4
+ T cells, including those phenotypically
defined as regulatory T cells (CD3
+CD4
+CD25
+FoxP3
+) in the
MLN or lung on days 7 or 9 p.i. (Fig. 5B). These time points have
been recently shown to reflect the peak and resolving response for
regulatory T cells following primary influenza virus infection [47].
Total organ cellularity in MLN, lung, and spleen were also
Maternal BPA Exposure and Influenza Infection
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the number of proliferating leukocytes, as detected by in vivo BrdU
incorporation assays (data not shown). We also compared the level
of influenza A virus specific antibodies in the circulation as another
indicator of the adaptive immune response to infection. On day 14
p.i., the levels of virus-specific total IgG, as well as virus-specific
IgG1 and IgG2a isotypes were similar between the two groups of
mice (Fig. 5C).
Maternal BPA Exposure did Not Influence Memory
Immune Responses
Several reports suggest that early life exposure to certain
pollutants reduces responses to routine childhood immunizations
[48–50], suggesting that mechanisms controlling immunological
memory are also potential targets of developmental toxicants. To
test this, 60 days after primary infection with HKx31, mice were
re-infected with a heterosubtypic strain of influenza A virus, PR8.
We intentionally administered a dose of PR8 that was empirically
determined to be lethal to naı ¨ve mice, but sub-lethal for immune
competent mice with preexisting T cell based immunological
memory. Using this strategy, we did not observe any difference in
the number of differentiated effector CTL (CTLe) or virus-specific
CD8
+ T cells in the lung, MLN, or spleen 10 days after secondary
infection (Fig. 6A-C). Moreover, the equivalent memory CD8
response correlated with equivalent disease outcomes, as demon-
strated by similar body weight loss patterns and survival in both
developmentally exposed groups (Fig. 6D,E). Consistent with these
results, we did not observe any differences in the antibody response
or lung inflammation in developmentally exposed mice that were
given a second influenza virus infection (data not shown).
Discussion
Infectious diseases remain among the major causes of illness and
death worldwide. There is mounting evidence that developmental
exposure to common chemicals from our daily environment
represents an overlooked contributor to differences in host
responsive capacity to infections [48–55]. Using the well
characterized immune response that develops following influenza
A virus infection, we created an assessment matrix that not only
Figure 1. BPA treatment does not change body weights of pregnant dams or the offspring. Pregnant dams were fed BPA spiked treats
every day starting on the 6
th day of gestation and continuing until 21 days after parturition (when the pups were weaned). Control dams received the
same daily treat, but spiked with the peanut oil vehicle. (A) On 16
th day of pregnancy a subset of dams were sacrificed 4 hours after eating spiked
treats or being gavaged with BPA (or vehicle), and the levels of BPA were measured in blood (limit of detection = 0.05 ng/mL; dashed line). (B) Dams
were weighed daily during pregnancy, and (C-E) the offspring were weighed on postnatal days 1, 7, 14 and 21. Pups were weaned on post-partum
day-21 into same sex groups and weighed on regular intervals until the age of 40 days. Data represent mean 6 SEM (n$20/group).
doi:10.1371/journal.pone.0038448.g001
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and altered host defenses against respiratory infections, but
examined the effects of developmental exposure to BPA on
several measures of innate and adaptive immune function known
to play key roles in combatting infection. In many ways, our
findings should be perceived as good news. Although concerning
effects of low level exposure to BPA on reproductive cancers have
been reported [56,57], our findings indicate that the function of
Figure 2. Developmental exposure to BPA does not alter primary disease outcomes from infection with influenza A virus.
Developmentally exposed adult offspring were infected with influenza virus (HKx31). All mice were monitored for (A) body weight loss and (B)
mortality for a period of at least 30 days post infection (n=55/group). (C) To determine pulmonary viral burden, sub-groups of infected mice were
sacrificed 3, 5, 7 or 10 days after infection and lungs were harvested (n$5/group/time point). Viral FFU per lung per animal was determined by
incubating lung homogenates on MDCK cells, as described in the Material and Methods section. The gray dotted line represents the limit of detection
for the assay. Data represent mean 6 SEM, and depict findings in female offspring. Parallel assessments were conducted in male adult offspring, and
yielded similar results (data not shown).
doi:10.1371/journal.pone.0038448.g002
Figure 3. Maternal BPA exposure alters the tissue pathology following influenza A virus infection. Adult offspring of treated dams were
infected with influenza virus (HKx31). To examine lung pathology, sub-groups of infected mice were sacrificed 3, 7 or 10 days following infection and
lungs were fixed in-situ with 10% neutral buffered saline. Paraffin embedded tissues were cut in 5 mM think sections and stained with H&E. (A)
Representative images of tissue sections from infected female mice are depicted. All images are at the same magnification. (B) Tissue sections from all
mice in each group were scored based on the degree of inflammatory cell accumulation, as outlined in the Materials and Methods section. Data in
the graphs represent mean 6 SEM (n=5/group/time point); *p#0.05.
doi:10.1371/journal.pone.0038448.g003
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largely unaffected by developmental exposure to BPA. Correlating
with no change in the host’s ability to mount adaptive immunity
against influenza virus infection, BPA exposure during develop-
ment did not adversely affect host resistance to primary or recall
infection. Based on these observation it appears that, in contrast to
several other pollutants, such as dioxins and polychlorinated
biphenyls, tobacco smoke, and lead [22,23,35,49,58–60], devel-
opmental exposure to BPA does not have significant influence on
the magnitude or functional capacity of the antigen-specific
adaptive component of the immune system.
Others have reported that early life BPA exposure correlated
with an increase in lymphocyte functions, such as elevated Th2
cytokine production following a bacterial infection, or enhanced T
cell and antibody responses following immunization with foreign
proteins [17–19]. One possible explanation for these differing
observations is that BPA acts on cellular mechanisms important
for driving Th2-polarized, but not Th1-polarized, immune
responses. That is, the effects of BPA on the immune system
could mimic the effects of estrogens, by skewing the Th1/Th2
balance in favor of Th2 responses [61–63]. However, the idea that
estrogens polarize toward Th2-biased responses is likely an
oversimplification of the physiological and pharmacological effects
of endogenous and exogenous estrogens on immune function [64],
and therefore is probably not an adequate explanation. Other
explanations for differences between our findings and prior reports
include the dose administered, as well as the timing and route of
exposure. Some of the studies in which altered immune function
was reported used doses of BPA that were 10–100 fold higher.
This may be a critical difference, as mice treated in our study had
circulating BPA levels on par with levels reported in the general
population. Moreover, in some of the other studies lower doses of
BPA were used, and reported to have no effect on ex vivo immune
cell functions or disease progression in vivo [17–19]. Similarly,
direct exposure of mature animals to BPA, often in the mg/kg/day
dose range, affected proliferation and cytokine production by ex
vivo re-stimulated lymphocytes, but in vivo exposure in the mg/kg/
day range did not alter these metrics or affect disease progression
Figure 4. Gene expression in the lung following influenza virus infection. Adult offspring of the vehicle or BPA treated dams were infected
with influenza A virus (HKx31) and lung tissues were harvested 0 (uninfected), 3, 7 or 10 days after infection. The levels of expression for the indicated
genes were determined using qRT-PCR and normalized to the expression of gene for a ribosomal protein L13. The bar graphs depict the mean fold
increase in the level of gene expression on different days following infection, relative to the level in uninfected animals from the same treatment
group. BPA exposure did not affect the expression of any of these genes in naı ¨ve mice (not shown). Data represent mean 6 SEM (n$5/group);
*p#0.05.
doi:10.1371/journal.pone.0038448.g004
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monotonic toxicity, is important to note that we also examined the
consequences of maternal exposure to lower doses of BPA [0.5 and
5 mg of BPA/kg body weight/day] administered in the same
dosing paradigm as the studies reported herein. We did not
observe any differences in the primary immune response to
influenza A virus infection in mice developmentally exposed to
these doses of BPA (data not shown). Thus, the dose of BPA
administered, particularly doses above 50 mg/kg/day, may mod-
ulate immune cell behavior, but there is no consensus on the
relationship between doses to rodents in the mg/kg/day range and
current human exposure.
Regulatory T cells can suppress the CD8 T cell response during
virus infections [68–70]. It has been also reported that develop-
mental exposure to BPA alters the magnitude of the regulatory T
cell population [17,18]. Using a transgenic mouse strain, one study
showed that developmental exposure to BPA induced oral
tolerance, and suggested that BPA might have effects on T cell
selection and activation processes that involve clonal deletion and
regulatory T cells [18]. However, in the current study, we did not
Figure 5. Mice maternally exposed to BPA mount an equivalent adaptive immune response to infection with influenza virus. Adult
offspring of the treated dams were infected with influenza virus (HKx31). (A) Mice were sacrificed 9 days post-infection and immune cells were
isolated from MLNs and lungs and stained with MHC class I-restricted tetramers and monoclonal antibodies, as described in the Materials and
Methods section. The number of CD3
+CD8
+ T cells (denoted as CD8
+), CD3
+CD8
+CD44
hiCD62L
lo cytotoxic effector CD8 T cells (denoted as CTLe), D
b/
PA224–233 and D
b/NP366–374 specific CD8 T-cells (denoted as D
b/PA
+ and D
b/NP
+, respectively) were measured by flow cytometry. (B) Mice were
sacrificed 7 or 9 days post-infection and immune cells were isolated from lungs and MLNs. The numbers of CD3
+CD4
+CD25
+FoxP3
+ T cells (Treg) were
measured by flow cytometry. (C) A separate group of infected developmentally exposed mice were euthanized 14 days p.i., and blood was collected.
The average amount of influenza virus-specific total IgG as well as virus-specific IgG1 and IgG2a isotypes in plasma were measured using ELISA. Data
shown are from adult female offspring; male offspring were also examined and findings were similar (data not shown). All data represent the mean
(6SEM) of the total number of the specified cell types recovered from each organ (A-B) or from blood (C) of individual mice (n$5/group/time point).
doi:10.1371/journal.pone.0038448.g005
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number of CD4 T cells or CD4
+CD25
+FoxP3
+ regulatory T cells
in the MLN or lung. This finding is consistent with our
observation that the overall CD8 T cell and antibody responses
to infection did not differ between treatment groups. It is
important to note that although the specific CD8 T cell population
detected 9 days after infection may appear to be of greater
magnitude in BPA exposed animals, no statistically significant
differences in the mean percentage or number were observed in
this or in independent repeats of this entire experiment. Thus, we
conclude that the subtle changes observed in BPA exposed animals
are unlikely to indicate a modification in the functional aspects of
adaptive immunity that mediates virus clearance. In addition to
the primary T cell response, our data also showed that
developmental exposure to BPA did not compromise the ability
to generate or execute an effective T cell based memory immune
response. To our knowledge, this is the first demonstration of the
consequences of developmental exposure to BPA on T cell based
memory to an infection. Assessment of memory immune responses
has implications beyond virus infections. For example, vaccines
are intended to generate host protective immunological memory.
An increased susceptibility to infection associated with exposure to
environmental agents could result from reduced vaccine efficacy.
Our data suggest that developmental exposure to BPA most likely
would not interfere with efficacy of any vaccine intended for
generating long-term T cell memory. Although we did not test
antibody-based immune memory directly, our data show that
development exposure to BPA had no effect on the ability of B
cells to produce antibodies or undergo isotype class switching;
from which we infer that a detrimental effect of early life exposure
to BPA on antibody-based memory is also unlikely.
Although maternal BPA exposure impaired neither the magni-
tude nor the effectiveness of adaptive immunity, we did observe a
reduction in pulmonary inflammation and cytokine expression
Figure 6. Developmental exposure to BPA does not adversely affect immune memory responses. Adult offspring of the treated dams
were infected with influenza virus (HKx31, H3N2). Sixty days after infection with HKx31, mice were re-infected with a heterosubtypic strain of
influenza A virus (PR8, H1N1). (A-C) Immune cells were isolated from lungs either before or 10 days after PR8 infection and stained with MHCI-
restricted tetramers and monoclonal antibodies. The frequency of (A) influenza PA224–233 peptide specific (D
b/PA
+), (B) influenza NP366–374 peptide
specific (D
b/NP
+) and (C) CD44
hiCD62L
lo cytotoxic effector CD8 T cells (CTLe) were determined by flow-cytometry. The graphs represent the mean
number (6SEM) of the indicated cell population recovered from infected lungs (n$7/group). Similar results were obtained from cells isolated from
spleen and MLNs (data not shown). (D,E) A separate group of developmentally exposed mice were monitored daily for (D) body weight loss and (E)
survival from the day before primary (HKx31) infection, through to 20 days after secondary (PR8) infection. Data represent mean 6 SEM (A-C, n.5/
group/time point; D-E, n=40/group). Statistical analyses were performed as described in the Materials and Methods. There were no significant
differences in the mean values between treatment groups.
doi:10.1371/journal.pone.0038448.g006
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associated with the variation seen in the lung virus titer of the
mice. These observations suggest that developmental exposure to
BPA may transiently diminish aspects of the inflammatory
response to infection. Seven days post influenza virus infection
in mice, two major lung infiltrating leukocyte populations are
neutrophils and macrophages, and production of TNF-a and
iNOS are hallmark functions of these cells [43–46]. Diminished
expression of these genes in the infected lung suggests that
developmental exposure to BPA might have some effects on
inflammatory mediators, which can be produced by leukocytes or
the structural cells of the lung. Several in vitro studies have shown
that exposure to BPA diminishes functions of neutrophils and
macrophages, including the production of TNF-a and nitric oxide
[71–73]. An influence of maternal BPA exposure on cytokine
production has also been reported in several animal models
[17,18]. Given that the level of inflammatory cytokines is
associated with the physical malaise experienced during influenza
virus infection [41,42], it is possible that changes in cytokine
production influence disease severity. However, using body weight
as a measure of morbidity, we observed no evidence for this idea
using two different strains of influenza virus. Interestingly, during
the early days after infection, which is dominated by innate
immune mediators, we observed slightly higher lung virus titers in
some of the animals that were developmentally exposed to BPA.
Although not statistically significant, this was observed in more
than one study. Such a difference could be a consequence of
reduced inflammation in the lung at that time, since early innate
immune responses play a critical role in containing the virus
during the early stages following infection [24]. At present we do
not know whether the influence of BPA on lung inflammation is a
result of direct effects of BPA on hematopoietic stem or progenitor
cells that are exposed during development, or the result of an
indirect effect of BPA, via endocrine or other systems that interact
with hematopoietic or lung cells, and which could have been
altered by developmental exposure to BPA. Moreover, whether
and how early life exposure modulates diseases in which tissue
inflammation plays a role in initiation of pathology remains to be
determined. Our observations in the influenza-infected lung
suggest that early life exposure may lead to attenuated rather
than enhanced tissue inflammation.
To our knowledge, the current study is the first comprehensive
investigation on the effects of developmental exposure to BPA on
host resistance that integrates different aspects of immunity and
quantitatively evaluates those parameters in a disease-specific
manner. We demonstrate here that developmental exposure to low
doses of BPA had only mild effects on the immune response to
influenza A virus infection, and did not compromise the ability of
the infected host to successfully clear the virus. Evidence exists that
exposure to certain environmental agents can selectively affect
some components of the immune system, and may even show
pleiotropic effects on certain aspects of the immune response
[22,23,52,74–76]. Since the immune system is composed of
multiple cell and tissue types, each having specific but overlapping
contributions to overall host resistance, it is not surprising to
observe subtle immunomodulation in one component of the
antiviral response without an overall effect on virus clearance and
disease outcome. Given that high doses of BPA have been shown
to act as xenoestrogens in-vitro [6,61], and considering the intricate
relationship between the immune and endocrine systems, it is
plausible that some BPA-mediated endocrine disruptive mecha-
nism might be responsible for the transient depression in innate
immunity that we observed following influenza virus infection.
Alternatively, BPA could also have direct effects on cells that
mediate innate immunity, such as down regulation of NF-kB
pathways, as suggested by other in vitro studies [72]. Although the
transient reduction in innate immunity did not negatively affect
influenza virus clearance, in a different scenario wherein the
inflammatory responses is critical for early pathogen clearance
(e.g., certain bacterial infections), a reduction in innate immune
functions from BPA exposure might prove detrimental. On the
other hand, during innate immune-mediated diseases, such as
chronic inflammation, BPA-mediated reductions in innate im-
mune functions might have beneficial effects. While all these ideas
are experimentally testable, the totality of our findings suggest that
developmental exposure to low oral doses of BPA did not
compromise the key aspects of anti-viral immunity to influenza
virus infection.
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